Efficacy and Safety Of Fractional Carbon Dioxide Laser Plus Topical Metformin In Treatment Of Acanthosis Nigricans

ConditionAcanthosis Nigricans

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age18-50

SponsorAl-Azhar University

About this trial

evaluate and compare the clinical Efficacy \& Safety Of Fractional Carbon Dioxide (Co₂) Laser Plus Topical Metformin In Treatment Of Acanthosis Nigricans.

Eligibility criteria

Qualifiers

- male or female patients aged 18-50 years

clinically & dermoscopy diagnosed acanthosis nigricans involving the neck

skin types iii-v

stable systemic condition for at least 3 months

Disqualifiers

- pregnancy or lactation

malignancy-associated acanthosis nigricans

active skin infection or inflammatory dermatosis at the treatment site

history of keloid or hypertrophic scar formation

Trial design

Treatments tested in this trial

Topical metformin

Treatment groups

34 Participants

are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Al-Azhar University

Lead sponsor

Source ClinicalTrials.gov